Objective: To examine the effects of low-carbohydrate, ketogenic (LCKD) and low-fat (LFD) diets on acid-base status. Design: Prospective analysis of volunteers from two clinical trials. Participants: Subset of 39 volunteers from a randomized trial comparing the effects of an LCKD with an LFD, and a single-arm trial of an LCKD. Setting: Outpatient research clinic. Intervention: LCKD (initially o20 g of carbohydrate daily) or LFD (o30% of energy from fat, 500-1000 kcal energy reduction) instruction. Measurements: Arterial blood gas analysis, serum chemistries (electrolytes, urea nitrogen/creatinine, glucose, ketone bodies, lactate), anion gap, and urine ketone bodies measured at weeks 0, 2, 8, and 24. Results: Participants had a mean (7standard deviation) age of 43.579.3 years; 28 (72%) were female, 29 (74%) were Caucasian. Using linear mixed-model analysis to examine blood test changes from baseline to 24 weeks, the LFD group experienced a decrease in arterial blood pH from a mean of 7.43 at week 0 to 7.40 at week 24 (P ¼ 0.03), and the LCKD group experienced a decrease from 7.42 at week 0 to 7.40 at week 24 (P ¼ 0.01). The lowest pH measurements observed were 7.34 in the LFD group and 7.37 in the LCKD group. Although serum bicarbonate appeared to decrease from baseline at weeks 2 and 8 in the LCKD group, the change at 24 weeks was not statistically significant in either diet group, and only four of 131 (two of 92 from the LCKD group) measurements were less than 22 mmol/l. The proportion of participants with elevated urine and serum ketone body levels rose in the LCKD group only, was highest at week 2, and decreased over the subsequent time points. Conclusion: In individuals following an LCKD or an LFD, blood pH decreased mildly and the LCKD group experienced a small, transient decrease in serum bicarbonate in conjunction with mild ketosis. This suggests that an LCKD induced a mild compensated metabolic acidosis, but no individual showed evidence of significant metabolic derangement.
Introduction
Low-carbohydrate diets have gained popularity even though research regarding the metabolic effects of these diets is just emerging. The most restrictive of these diets lower carbohydrate intake to the point of inducing a shift in metabolism. The reduced carbohydrate availability stimulates lipolysis, producing fatty acids and ketone bodies for use as alternative fuel sources. Nearly all cell types in the human body can use these alternative fuels although some (e.g., myocardium) prefer fatty acids, whereas others (e.g., brain) can only use ketone bodies. Ketone bodies are detectable in the serum, urine, and breath (Azar and Bloom, 1963; Young et al., 1971; Rabast and Kasper, 1978; Rabast et al., 1981) , and in fact, urine and breath ketone body tests are sometimes used to monitor for adequate carbohydrate restriction by lowcarbohydrate diet followers (Larosa et al., 1980) . Ketone bodies have an acidic pK and are best known for causing ketoacidosis, a serious condition that can cause acidemia in diabetic and alcoholic patients. Acidemia is said to exist when the arterial blood pH is below normal (normal range is 7.35-7.45 at our facility) (Seifter, 2004 ). An acidosis is the individual process that drives the blood pH downward, although because multiple processes may coexist, an abnormal pH is not required for there to be an acid-base disturbance. Metabolic acidosis occurs when the primary acid-base disorder is a decrease in serum bicarbonate concentration; this frequently occurs when bicarbonate is needed to compensate for (buffer) acid metabolites (Seifter, 2004) . Ketosis, therefore, is a type of metabolic acidosis and is a condition characterized by the enhanced production of ketone bodies, whereas ketonemia is the presence of recognizable concentrations of ketone bodies in the plasma (Hensyl, 1990) .
Individuals following low-carbohydrate diets that restrict carbohydrate intake to a level that induces ketogenesis (lowcarbohydrate ketogenic diet or LCKD) apparently experience ketonemia without illness or known complication. It is assumed that the ketonemia induced by these diets is tolerated, based on those research studies that have measured ketone body production (Phinney et al., 1983; Langfort et al., 1996; Volek et al., 2002; Brehm et al., 2003 Brehm et al., , 2005 Meckling et al., 2004; Yancy et al., 2004; Boden et al., 2005) . It is not known, however, if actual acidemia develops. After a literature search, we were unable to find any studies that reported the detailed acid-base effects of these particular diets (Westman, 1999; Volek et al., 2002; Brehm et al., 2003 Brehm et al., , 2005 Meckling et al., 2004; Yancy et al., 2004; Boden et al., 2005) . None of the studies provided arterial blood gas (ABG) analysis results or even full electrolyte panels in order to calculate an anion gap, which can be used as an indicator of metabolic acidosis. In light of recent case reports of ketoacidosis associated with low-carbohydrate diets, this information is needed to judge the safety of such diets (Chen et al., 2006; Shah and Isley, 2006) .
The purpose of this study was to use ABG and serum chemistry measurements to examine the acid-base status of individuals following two weight loss diets, one of which was an LCKD, on an outpatient basis for 6 months.
Methods

Participants
At the initial visit (before starting the diet intervention) for each group in a randomized, controlled trial comparing the LCKD with a low-fat diet (LFD) in individuals with hyperlipidemia (Yancy et al., 2004) and in a single-arm pilot study of the LCKD in individuals without hyperlipidemia, participants were asked to volunteer for this ancillary study that required extra blood specimens (arterial and venous) to be taken at return visits. Exclusion criteria were an abnormal modified Allen's test or any established peripheral vascular disease, arterial anomaly, skin abnormality, bleeding diathesis or anticoagulant medication that precluded arterial puncture. Each volunteer provided written informed consent approved by the institutional review board. Intervention LCKD group. Using handouts based on a popular lay press diet book (Atkins, 1998) , the investigators instructed participants to restrict carbohydrate intake, initially to less than 20 g of carbohydrate per day. Participants were permitted unlimited amounts of meat and eggs, and limited amounts of hard cheese and vegetables each day (Yancy et al., 2004) . As participants approached their goal weight, they were advised to add approximately 5 g of carbohydrates to their daily intake each week until they reached a level where weight was maintained. The LCKD group also received daily nutritional supplements (multivitamin, essential oils, diet formulation and chromium picolinate, see Appendix).
LFD group. Using a commonly available booklet and additional handouts, a registered dietician instructed participants in a diet that had o30% of daily energy intake from fat, o10% of daily energy intake from saturated fat and o300 mg cholesterol daily (Anonymous, 1994 (Anonymous, , 2000 . Individuals were instructed to reduce energy intake by subtracting 500-1000 kcal from their calculated weight-maintenance energy intake (body weight in lbs Â 10) (Duyff, 1998) .
Both diet groups. Participants were regularly advised to drink at least 6-8 glasses of water or other clear fluids daily. In addition, participants were encouraged to exercise for 30 min at least three times per week, but no formal exercise program or incentives were provided.
Primary outcome measures
All measurements were collected at weeks 0, 2, 8, and 24 during regularly scheduled group meetings. ABG analysis provided the main outcome, serum pH. Arterial puncture was performed in the standard manner at the radial artery using a heparinized syringe after a modified Allen's test was noted to be normal. The arterial blood specimen was immediately placed on ice and transported to the laboratory within 1 h for analysis by a Bayer 855 blood gas analyzer.
The blood specimen for serum sodium, potassium, chloride, bicarbonate, urea nitrogen, creatinine and glucose was placed in a serum separator tube and remained at room temperature until analysis by a Beckman LX20 analyzer. The anion gap was calculated from serum electrolyte measurements in the following manner: anion gap ¼ sodium chloride -measured bicarbonate. The blood specimen for serum ketone bodies came from the serum separator tube and was analyzed by a Bayer Acetest analyzer (sodium nitroprusside reagent, which tests for acetone and acetoacetate) with the following ordinal 5-item scale: none, trace (up to 20 mg/dl), small (20 mg/dl), moderate (30-40 mg/dl), or large (80-100 mg/dl). Urine ketone bodies were analyzed by the same reagent with the following ordinal six-item scale: none, trace (up to 5 mg/dl), small (5-40 mg/dl), moderate (40-80 mg/dl), large80 (80-160 mg/dl), and large160 (4160 mg/dl). Urine or serum ketone body level was considered elevated if above 'none.' The blood specimen for serum lactate was obtained in a sodium fluoride (stabilizer)/potassium oxalate (anticoagulant) tube and kept on ice until analysis by a Beckman LX 20 analyzer. In this assay, lactate is converted into pyruvate and hydrogen peroxide by lactate oxidase, followed by a peroxidase indicator reaction.
Statistical analysis
Linear mixed-effects models (PROC MIXED in SAS) including fixed and random effects were used to analyze the effect of the diet group assignment on weight loss and each of the laboratory measurements. Linear mixed-effects models are a flexible class of models that can be used to analyze expected mean change over time, making efficient use of all available measurements (Cnaan et al., 1997) . The random effects part of the model takes into account the natural heterogeneity of the subjects as well as the lack of independence that occurs in repeated measurements from a single subject. Furthermore, in these models, we used an unstructured covariance matrix for the repeated measurements (i.e., no function of time). This type of structure allows for unequal correlations between consecutive time points, making it more ideal (than an ANOVA-type model) for unequally spaced time points. The fixed effects included in the models were duration of intervention (i.e., week of visit, treated as a class variable), diet group, and the interaction between week of visit and diet group. The correlation between serum pH and the concentration of serum ketone bodies was examined using Spearman's rank order correlation coefficient for ordinal data. A P-value of o 0.05 was considered statistically significant. Analyses were performed using SAS Statistical Software, Version 8.02. (SAS Institute, Cary, NC, USA) and S-Plus 7 (Insightful Corp., Seattle, WA, USA).
Results
Participants
Forty participants volunteered for the study, 28 from the LCKD group and 12 from the LFD group. One participant from the LCKD group was not enrolled because baseline arterial blood sample could not be obtained, resulting in 27 participants in the LCKD group. There were no statistically significant differences in baseline characteristics between diet groups (Table 1 ). The mean age was approximately 43 years; the majority of participants were women and of white race. The mean body mass index (BMI) was 36 kg/m 2 . In both diet groups, participants who completed follow-up appeared to be older, more likely to be male, and more likely to be of white race compared with those who did not complete follow-up but these differences did not reach statistical significance (Table 1) .
Body weight
By mixed model analysis, using data from all participants, including those who discontinued the study, the mean weight change was À16.3 kg for the LCKD group and À6.4 kg for the LFD group (Po0.001 for comparison).
Laboratory measurements
Using a mixed-model analysis to examine blood test changes over the 24-week duration, the LFD group experienced a statistically significant change only in arterial blood pH from a mean of 7.43 at week 0 to 7.40 at week 24 (P ¼ 0.03, see Table 2 ). In the LCKD group, mean arterial blood pH decreased from 7.42 at week 0 to 7.40 at week 24 (P ¼ 0.01). Combining measurements at all time points for both diet groups, arterial blood pH ranged from 7.34 to 7.48 with seven of 126 (five of 88 from LCKD group) measurements less than 7.38. No individual in the LCKD group had a measurement below 7.37 at any time point (Figure 1a and b) . In the LCKD group, there were statistically significant, but clinically insignificant, decreases in serum sodium, potassium, and chloride over the 24 weeks (P ¼ 0.002, 0.01 and 0.04, respectively). Serum bicarbonate did not change significantly over the 24 weeks in either diet group. For both diet groups, bicarbonate levels ranged from 18.5-32.0 mmol/l with four of 131 (two of 92 from LCKD group) measurements less than 22 mmol/l. The calculated anion gap also did not change significantly from week 0 to week 24. In both diet groups, anion gap ranged from 3.4 to 16.0 with There were no statistically significant differences in baseline characteristics between diet groups, or between completers vs non-completers.
sevenof 131 (seven of 92 from LCKD group) measurements greater than 11. In the LCKD group, serum lactate decreased over the 24 weeks from a mean of 1.23 to 0.94 mmol/l (P ¼ 0.02), whereas urea nitrogen increased from a mean of 5.11 to 6.21 mmol/l (P ¼ 0.002); serum creatinine did not change significantly. In comparisons between diet groups, the 24-week change in blood urea nitrogen in the LCKD group was statistically different from that of the LFD group (1.11 vs -0.71 mmol/l, P ¼ 0.008). There were no other statistically significant differences between groups (Table 2) . Urine and serum ketone body measurements for each time point by diet group are displayed in Table 3 . At week 0, most participants in both diet groups had negative urine and serum ketone body measurements. Urine and serum ketone body measurements remained negative for almost all LFD group participants throughout follow-up. For the LCKD group, most participants had ketone bodies detectable in the urine at weeks 2, 8, and 24, although the percentage decreased over time. The majority of LCKD participants also had ketone bodies detectable in the serum at weeks 2 and 8, 
Discussion
In this study, there was a statistically significant, yet clinically small, decrease in mean serum pH for followers of either an LCKD or an LFD. No individual on the LCKD had a serum pH measurement below 7.37, with the lower limit of normal range being 7.35. Despite previous case reports of acid-base disturbance in two individuals following similar diets, we did not observe this disturbance in our sample of participants (Shah and Isley, 2006; Chen et al., 2006) . In the LCKD group, mean serum bicarbonate decreased and mean anion gap increased early in the study but then returned to baseline, indicating that a compensated metabolic acidosis may occur soon after initiation of an LCKD. Accordingly, the proportion of LCKD participants with elevated urine and serum ketone body levels was highest early in the study and decreased over time. Regardless of duration on the diet, the serum pH did not appear to be related to the concentration of serum ketone bodies. This likely reflects that the buffering capacity of the body can accommodate the relatively low concentrations of ketone bodies (as compared with diabetic or alcoholic ketoacidosis) that have been observed in individuals following an LCKD.
As ketosis is a goal in the most restrictive low-carbohydrate diets, some low-carbohydrate diet followers use urinary ketone strips to verify sufficient carbohydrate reduction. Several studies have confirmed ketonuria by urine dipstick or ketonemia by measurement of serum b-hydroxybutyrate in subjects following a low-carbohydrate diet (Azar and Bloom, 1963; Young et al., 1971; Rabast and Kasper, 1978; Rabast et al., 1981; Volek et al., 2002; Brehm et al., 2003 Brehm et al., , 2005 Meckling et al., 2004; Yancy et al., 2004; Boden et al., 2005) . Furthermore, some data suggest an inverse relationship such that urinary ketone body levels increase as carbohydrate intake decreases (Young et al., 1971) . However, the data also show significant subject to subject variability in urinary ketone body response even when subjects are provided strictly uniform diets (Azar and Bloom, 1963) . Most of the recent studies of the LCKD note that the level of ketosis decreases with time; (Volek et al., 2002; Brehm et al., 2003 Brehm et al., , 2005 Meckling et al., 2004; Yancy et al., 2004; Boden et al., 2005) this effect occurs in studies of both short (14 days) (Boden et al., 2005) and longer (6 months) (Brehm et al., 2003; Yancy et al., 2004) duration. It is unclear whether this effect is a result of the body's increased efficiency over time at utilizing ketone bodies for energy or a decrease in the production of ketone bodies over time, presumably from adding carbohydrates back into the diet. However, one inpatient study that closely controlled carbohydrate intake at 21 g daily also observed this effect over 2 weeks of daily urine ketone body measurements, suggesting that the former hypothesis at least plays a role (Boden et al., 2005) . Notably, the present study allowed the LCKD dieters to restrict carbohydrate intake to the typical level of ketogenesis longer than what is recommended in several popular lay-press diet books, which employ this restrictive phase for only the first 2 weeks of the weight loss process.
Comparing laboratory changes between diet groups, there was a statistically significant increase in blood urea nitrogen in the LCKD group, but not the LFD group. This effect has been reported in other studies of the LCKD and may result Each cell contains the percentage of individuals in one diet group with measurements performed at one timepoint who had the specified ketone reading. Columns might not add exactly to 100% due to rounding.
from an increase in dietary protein or a decrease in intravascular volume. Another interesting finding that occurred in the LCKD group only was a statistically significant reduction in lactate. This is consistent with a presumed overall shift from glycolysis (anaerobic, lactateproducing) to fat metabolism (aerobic). One limitation of our study is that the small sample size might explain the lack of significant changes observed in the LFD within-group analyses and in comparisons between the two diet groups. Additionally, because this was an outpatient diet intervention, dietary intake was not explicitly controlled and measurements were made infrequently. More accurate assessment of how much and when carbohydrate restriction affects acid-base status might be obtained from an inpatient study. However, our study more likely represents these effects in a more real-world setting.
In conclusion, in individuals following an LCKD or an LFD for 24 weeks, mean blood pH decreased slightly with a mild transient decrease in serum bicarbonate and a mild transient increase in anion gap observed only in the LCKD group. These changes occurred in conjunction with a mild ketosis. These data suggest that an LCKD induces a mild compensated metabolic acidosis. However, none of the individuals displayed evidence of a significant metabolic derangement. 
